Weizmannia coagulans BC99 presents promising probiotic strategy for chronic constipation
A study in China supports Weizmannia coagulans BC99’s potential to enhance intestinal motility, regulate gut microbiota and increase SCFA production.
China 中国
聚焦日本：大冢制药、养乐多的肠道健康影响力、药物警戒等
了解日本营养保健品市场的最新发展，包括大冢制药的山柰酚补充剂及其在华扩张、一项新的药物警戒调查、养乐多在欧洲的肠道健康影响力等。
趋势追踪：中国保健食品贸易数据，印度营养保健品企业并购动态
在本期综合新闻中，了解更多关于去年中国保健食品贸易统计数据的趋势、印度营养保健品行业的一系列并购交易等信息。
科学短报：肌酸参考摄入量、咖啡果皮提取物与甜菜根
本期综合新闻重点介绍了最新的健康和营养研究，包括探讨为健康成年人制定肌酸膳食参考摄入量、咖啡果皮提取物降低胆固醇的潜力，以及运动员使用甜菜根汁的研究。
监管审查：保健食品出口、Magtein 批准等
本轮监管综合新闻中的最新动态包括：中国对海外生产的保健食品的工厂注册政策、Magtein 在英国获批，以及欧洲食品安全局 (EFSA) 对含小檗碱植物公开征求意见。
聚焦中国：阿里巴巴天猫热销品类、蛋白质消费等资讯汇总
本期综合新闻包括阿里巴巴天猫平台上销售收入最高的品类、中国的蛋白质消费增长与体重管理意识等。
China focus: Biggest sales categories on Alibaba Tmall, protein consumption and more
This round-up looks at news including the categories with biggest sales revenue on Alibaba Tmall, protein consumption growth and weight management awareness in China, and more.
Energy and sports drinks demand is robust in China, says Eastroc
There is “robust” demand for functional drinks such as energy beverages and sports drinks in China, says Eastroc, which reported a 17.3% increase in energy beverage sales and a 119% growth in sales of its sports drinks last year.
Alibaba Tmall breaks down biggest health foods categories in China
Vitamin and mineral supplements, cardiovascular health supplements and kids nutrition are the three biggest nutraceutical categories in China in terms of sales revenue, according to major e-commerce channel Alibaba Tmall.
Protein users expanding in China, says BYHEALTH on new product launch
Protein consumption is growing in China across different consumer groups and demand for higher quality products is on the rise, says BYHEALTH, which has recently launched an upgraded version of its flagship protein powder product.
Pharmacy chain founder opens nutraceutical longevity start-up
Margarita Zhao, founder of a pharmacy chain and a pharmaceutical company in Inner Mongolia, has launched a nutraceutical start-up focused on longevity and healthspan products - at least for its initial launch.
聚焦日本：麒麟新设实体以及与子公司的研发合作、内服美容等更多动态
了解日本营养保健品市场的最新发展动态，包括麒麟集团成立新实体以及与子公司芳珂和澳佳宝推进免疫健康研发、亚太地区内服美容的增长驱动因素和市场机遇等。
趋势追踪：内服美容、能量袋装产品、NMN 等更多动态
本期综合新闻关注亚太地区内服美容市场趋势、能量袋装产品的兴起，以及澳大利亚烟酰胺单核苷酸 (NMN) 的零售现状。
科学短报：姜黄、大豆蛋白、药用蘑菇备受关注
本期综合新闻关注健康与营养领域的最新研究发现，包括姜黄掺假、大豆蛋白对肌肉健康的影响、药用蘑菇缓解焦虑的作用等内容。
监管审查：美国对中国和印度征收反倾销税、新 HMO 获批等更多动态
美国对某些国家的硬质空心胶囊征收反倾销税和反补贴税，以及中国批准 3′-唾液酸乳糖钠盐 (3′-SL) 用于婴幼儿配方奶粉——本期监管动态为您带来最新进展。
聚焦中国：a2 牛奶公司、大冢制药、HMO 获批等
本期综合新闻关注 a2 牛奶公司的婴幼儿营养业务、中国第三款 HMO 获批、大冢制药的新工厂、最新科学发现等内容。
China focus: a2 Milk Company, Otsuka Pharma, HMO approval and more
This round-up looks at news including a2 Milk Company’s infant nutrition business, the third HMO approval in China, Otsuka Pharma’s new factory, latest scientific findings and more.
Trade war impact: China’s health foods exports to the US slides 14.7% in 2025
The United States is China’s largest health foods export destination; however, exports were down 14.7% last year partly due to U.S. trade tariffs and changing trade policies.
Brand new: a2MC’s kids supplements debut, POCARI SWEAT factory, HUL acquisition
See new developments from health and nutrition brands across Asia-Pacific, including The a2 Milk Company’s kids supplements debut, POCARI SWEAT’s new factory and Hindustan Unilever (HUL) acquiring clean-label and women’s health firm OZiva.
China health foods stats: US still top exporter, Australia’s exports down 21.5%
The U.S. remained the top health foods exporter to China last year, followed by Germany where exports were up 15.5%, while Australia – once the top exporter between 2018 and 2020 – saw exports fall by 21.5%.
Haleon’s FY25 results: APAC supplements growth offsets US declines
Haleon saw strong sales growth in its health supplement business in Asia-Pacific last year, which it said has partly offset the decline in North America.
Otsuka Pharma beefs up POCARI SWEAT production in China
Otsuka Pharmaceutical Co. Ltd, the owner of the electrolyte drink POCARI SWEAT, is ramping up production in China with a newly opened factory in Tianjin.
聚焦日本：FFC 最新发现、麒麟的研发布局及更多动态
本期内容聚焦日本营养保健品企业和行业的最新进展，包括功能性标示食品 (FFC) 报告的最新发现、麒麟集团的研发重点，以及大谷翔平 (Shohei Ohtani) 出任“免疫护理”推广大使等动态。
趋势追踪：越南营养品市场、台湾消费者对复合维生素的看法、日本 FFC
本期综合新闻关注越南快速增长的营养保健品市场、台湾消费者对复合维生素矿物质产品的认知，以及日本热门的功能性标示食品 (FFC) 动态。
科学短报：天门冬根提取物、L-苏糖酸镁备受关注
本期综合新闻关注健康与营养领域的最新研究发现，包括天门冬根提取物在调节血糖与血脂方面的作用、L-苏糖酸镁对认知表现的益处等。
监管审查：BPOM与HSA合作、中国审批动态及更多资讯
印尼国家药品与食品监督管理局 (BPOM) 与新加坡卫生科学局 (HSA) 就保健品开展联合评估，以及中国批准关节健康相关功能声明——本期监管动态为您带来最新进展。
聚焦中国：Orthomol 业务扩张、监管审批及更多动态
本期综合新闻聚焦 Orthomol 的扩张计划、监管审批最新进展，以及最新市场数据和科研成果。
China focus: Orthomol’s expansion, regulatory approvals and more
This round-up looks at news including Orthomol’s expansion ambitions, regulatory approvals, as well as latest data and scientific findings.
聚焦日本：市场热点、最新研究动态等
一文速览日本营养保健品企业与市场的近期动态，包括日本跻身初创企业合作热门市场、行业最新研究成果等内容。
趋势追踪：澳大利亚、东南亚睡眠报告及保健品使用习惯
这份综述将带您了解澳大利亚与东南亚消费者的睡眠趋势，以及他们的保健品使用习惯。
科学短报：褐藻糖胶、复合维生素、东革阿里成关注焦点
本期综述聚焦健康与营养领域最新研究成果，涵盖：褐藻糖胶可改善握力的新证据、复合维生素需针对性补充的结论，以及东革阿里缓解更年期症状的功效。
监管审查：亚马逊 cGMP 规范、NMN、非新资源益生菌菌株
2026 年首期营养保健食品法规动态的最新进展包括：亚马逊针对所有膳食补充剂产品实施 cGMP 规范要求、澳大利亚药品管理局批准 NMN 用于膳食补充剂，以及欧盟委员会扩大非新资源益生菌菌株的使用范围。
聚焦中国：雀巢召回产品、新规落地、伊利布局健康老龄化领域等动态
本期综述涵盖雀巢多区域婴儿配方奶粉召回、2026 年新营养法规实施、伊利布局健康老龄化领域等要闻。
China focus: Nestlé recalls, new regulations, Yili diving into health aging and more
This round-up looks at news including Nestlé’s recall of its infant formulas across regions, new nutra regulations in 2026, Yili’s expansion into healthy aging, and more.
Dairy and beyond: Yili to grow healthy aging nutrition portfolio
China dairy giant Yili is going beyond general milk products and infant nutrition needs by diving into healthy aging needs against the backdrop of a greying population and increased consumer interest in metabolic health.
聚焦中国：Noromega、万宁、营养保健品进出口等
本期聚焦 Noromega 在华增长策略、Guardian 和万宁设立更年期产品专区、中国营养保健食品进出口数据等新闻。
科学短报：胶原蛋白、NMN 与长寿研究最新进展
本期为您带来健康与营养领域的最新研究发现，包括胶原蛋白改善皱纹与缓解膝盖疼痛、烟酰胺单核苷酸 (NMN) 促进生长期头发生长等突破性成果。
监管审查：假冒产品、含量不符、 NMN 合法化
本期监管动态为您带来最新进展，包括马来西亚公司 Holista Colltech 因旗下 Omega-3 产品遭遇假冒问题呼吁行业加强与监管机构沟通、澳大利亚监管机构警示进口褪黑素补充剂含量不符问题、美国 FDA 宣布 NMN 可作为膳食补充剂合法使用。
供应商综合新闻：聚焦普诺碧、Rousselot、Aker BioMarine 等企业动态
本期聚焦推动亚太营养保健品市场创新发展的供应商企业，包括普诺碧三夺 NutraIngredients 大奖、Rousselot 在亚洲扩大其专利软骨基质成分的市场布局，以及 Aker BioMarine 与新加坡企业就新成分达成东南亚 (SEA) 独家合作。
聚焦日本：麒麟、森永乳业、NMN 护发潜力新发现
本期聚焦日本营养保健品企业及市场动态，包括麒麟和三菱商事生命科学的研究成果、森永乳业首款情绪调节后生元等。
China focus: Noromega, Mannings, Nutra imports and exports, and more
This round-up looks at news including Noromega’s strategies that drove its China growth, Guardian and Mannings’ menopause-friendly product aisles, China’s nutraceutical imports and exports data, and more.
Will gummies lose dominance? 3 key market shifts expected in childhood nutrition
An analyst weighs in on current childhood nutrition trends as well as key market shifts that are expected to take place in the children supplements category.
Five market hotspots for start-up partnerships, according to Haleon
The Philippines, India, Taiwan, Japan, and China are the five markets deemed as the “most realistic” for launching start-up partnerships in the upcoming year, according to Haleon.
Vitafoods Asia 2025
Leveraging livestreaming: Noromega looks to replicate China success in Thailand
Norwegian supplements brand Noromega sheds light on the key strategies that drove its successes in China, which it seeks to replicate in Thailand.
TikTok clears nearly 800 sellers making exaggerated weight loss, health claims
Douyin, China’s version of TikTok, has clamped down on merchants promoting their general foods, beverages and supplement products via exaggerated weight loss and other unsupported health claims in a three-month long inspection.
Tariff impact: China health foods exports to US down 12.2% in first half 2025
China’s health foods exports to the US had fallen 12.2% year-on-year in the first half of 2025 – possibly a result of US tariffs policy – says a report by the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE).
聚焦日本：三得利、明治、大冢制药等
关注日本营养保健品企业及市场最新动向，包括三得利 CEO 因药物调查辞职事件引发的风波、明治的 NMN 胶原蛋白产品、大冢制药市场扩张等。
供应商最新动态：AstaReal、森永乳业、AAK 备受关注
本期综合新闻重点报道推动亚太地区营养保健品市场新发展的供应商公司，包括 AstaReal 在儿童眼部健康虾青素应用领域取得进展、森永乳业全球上市情绪调节后生元产品等。
监管审查：商品及服务税削减、GRAS 自我声明、保健食品安全法规
本期监管要闻聚焦三大动向：印度大幅削减营养保健品的商品及服务税、美国提议修订公认安全 (Generally Recognized as Safe, GRAS) 规定、中国即将对保健食品安全法规进行审查。
科学短报：乳清蛋白、南非醉茄、PEA 备受关注
在本期综合新闻中，我们为您报道有关健康和营养的最新研究成果，包括乳清蛋白、南非醉茄和棕榈酰乙醇酰胺 (PEA) 的新发现。